HAS2 and pancreatic neoplasm: ZEB1correlates negatively with ESRP1 and positively with HAS2 in NCI-60 and CCLE cellline cohorts and in lung, breast, and pancreatic tumors,38,39 indicating that feedback loops operatingamong ZEB1, ESRP1, and HAS2 may modulate cancer cell plasticity across subtypes.